ARTICLE SUMMARY:
After a few up-and-down years, PwC analysts expect the medtech industry’s appetite for mergers and acquisitions will return to historical averages as the large strategics are transforming their portfolios in search of faster growth and technological transformation.
Despite many ongoing challenges hindering investment innovation, the fundamental strengths of the medtech industry will soon drive more volume and value in medtech mergers and acquisitions, according to analysts with PricewaterhouseCoopers.
